M. Aalto

457 total citations
32 papers, 365 citations indexed

About

M. Aalto is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, M. Aalto has authored 32 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in M. Aalto's work include Connective tissue disorders research (6 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Tendon Structure and Treatment (3 papers). M. Aalto is often cited by papers focused on Connective tissue disorders research (6 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Tendon Structure and Treatment (3 papers). M. Aalto collaborates with scholars based in Finland, Sweden and Saudi Arabia. M. Aalto's co-authors include E. Kulonen, J Pikkarainen, Irma Matinlauri, A. G. Heppleston, Kirsti Näntö‐Salonen, Hilkka Turakainen, Kerttu Irjala, Tapani Rönnemaa, Pertti Koskinen and Juhani Vilpo and has published in prestigious journals such as Diabetes Care, FEBS Letters and Environmental Health Perspectives.

In The Last Decade

M. Aalto

31 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Aalto Finland 13 80 67 52 42 36 32 365
Richard Chapman United Kingdom 15 36 0.5× 118 1.8× 53 1.0× 26 0.6× 92 2.6× 32 859
Hisako Tanaka Japan 13 34 0.4× 107 1.6× 72 1.4× 40 1.0× 30 0.8× 37 449
Fiona R. Green United Kingdom 10 81 1.0× 145 2.2× 52 1.0× 35 0.8× 43 1.2× 13 556
Leonard J. Quadracci United States 9 70 0.9× 128 1.9× 67 1.3× 14 0.3× 13 0.4× 19 476
Ambrus Jl United States 11 67 0.8× 95 1.4× 35 0.7× 17 0.4× 22 0.6× 50 406
Cheryl Smythe United Kingdom 5 69 0.9× 135 2.0× 96 1.8× 74 1.8× 27 0.8× 9 464
Caen Jp France 11 106 1.3× 55 0.8× 29 0.6× 10 0.2× 19 0.5× 44 343
H. Wehinger Germany 12 47 0.6× 96 1.4× 44 0.8× 16 0.4× 9 0.3× 48 379
Ralph H. Starkey United States 7 43 0.5× 193 2.9× 144 2.8× 25 0.6× 96 2.7× 8 504
Martha-Maria Gebhard Germany 7 115 1.4× 91 1.4× 125 2.4× 29 0.7× 11 0.3× 8 478

Countries citing papers authored by M. Aalto

Since Specialization
Citations

This map shows the geographic impact of M. Aalto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Aalto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Aalto more than expected).

Fields of papers citing papers by M. Aalto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Aalto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Aalto. The network helps show where M. Aalto may publish in the future.

Co-authorship network of co-authors of M. Aalto

This figure shows the co-authorship network connecting the top 25 collaborators of M. Aalto. A scholar is included among the top collaborators of M. Aalto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Aalto. M. Aalto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tanner, Laura M., Kirsti Näntö‐Salonen, Mohamed S. Rashed, et al.. (2008). Carnitine deficiency and l-carnitine supplementation in lysinuric protein intolerance. Metabolism. 57(4). 549–554. 15 indexed citations
3.
Näntö‐Salonen, Kirsti, et al.. (2003). Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance. Metabolism. 52(7). 935–938. 14 indexed citations
4.
Mäkimattila, Sari, Paula Summanen, Irma Matinlauri, et al.. (1998). Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM. British Journal of Ophthalmology. 82(8). 939–944. 15 indexed citations
5.
Matinlauri, Irma, et al.. (1995). Total renin after gonadotropin stimulation in polycystic ovarian disease. Fertility and Sterility. 63(2). 307–313. 5 indexed citations
6.
Aalto, M., et al.. (1995). Third generation time-resolved immunofluorometric TSH assay for automatic immunoassay system evaluated. Scandinavian Journal of Clinical and Laboratory Investigation. 55(6). 537–541. 10 indexed citations
7.
Matinlauri, Irma, Ulla Ekblad, Pertti Koskinen, et al.. (1995). Total renin in pre-eclampsia. Clinica Chimica Acta. 234(1-2). 163–170. 5 indexed citations
8.
Matinlauri, Irma, et al.. (1995). Elevated Serum Total Renin Is Insensitive in Detecting Incipient Diabetic Nephropathy. Diabetes Care. 18(10). 1357–1361. 7 indexed citations
9.
Näntö‐Salonen, Kirsti, et al.. (1985). Urinary glycosaminoglycans in aspartylglycosaminuria: evidence for disturbed proteoglycan metabolism. Clinica Chimica Acta. 146(2-3). 111–118. 5 indexed citations
10.
Kulonen, E., et al.. (1984). Silica-released macrophage factor that stimulates protein synthesis in fibroblasts. Biochemical Society Transactions. 12(2). 256–257. 1 indexed citations
11.
Kulonen, E., et al.. (1983). Recent investigations on macrophage proteins and of fibroblast RNA in silicotic lung fibrosis.. PubMed. 7. 204–11. 5 indexed citations
12.
Kulonen, E., et al.. (1983). Fibroblast RNA and macrophage proteins (including the fibrogenic factor) in experimental silicosis.. Environmental Health Perspectives. 51. 119–124. 4 indexed citations
13.
Kulonen, E., et al.. (1982). Increase of RNA and appearance of new protein in silicotic lung tissue.. PubMed. 26(1-4). 463–71. 5 indexed citations
14.
Aalto, M., Matti K. Viljanen, & E. Kulonen. (1982). Neutralization of the fibrogenic silica-released macrophage factor by antiserum. Experimental Pathology. 22(3). 181–184. 4 indexed citations
15.
Aalto, M. & E. Kulonen. (1979). Fractionation of connective-tissue-activating factors from the culture medium of silica-treated macrophages.. PubMed. 87C(3). 241–50. 20 indexed citations
16.
Aalto, M., et al.. (1979). Glycoproteins from experimental granulation tissue and their effects on collagen synthesis in embryonic chick tendon cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 587(4). 606–617. 5 indexed citations
17.
Aalto, M., Hilkka Turakainen, & E. Kulonen. (1979). Effect of SiO2-liberated macrophage factor on protein synthesis in connective tissue in vitro. Scandinavian Journal of Clinical and Laboratory Investigation. 39(3). 205–213. 4 indexed citations
18.
Aalto, M., et al.. (1976). The effect of silica-treated macrophages on the synthesis of collagen and other proteins in vitro. Experimental Cell Research. 97(1). 193–202. 52 indexed citations
19.
Aalto, M., et al.. (1973). Amino acid metabolism of experimental granulation tissue in vitro. Biochemical Journal. 132(4). 663–671. 26 indexed citations
20.
Aalto, M. & E. Kulonen. (1972). Effects of serotonin, indomethacin and other antirheumatic drugs on the synthesis of collagen and other proteins in granulation tissue slices. Biochemical Pharmacology. 21(21). 2835–2840. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026